South Korea Gene Therapy Market to 2032
Overview
The South Korea Gene Therapy Market is expected to reach a 1,142.92 USD Billion by 2032 and is projected to grow at a CAGR of 28.70% from 2025 to 2032.
Revenue, 2024 (USD Billion)
277.14
Forecast, 2032 (USD Billion)
1,142.92
CAGR, 2024 - 2032
28.70%
Report Coverage
South Korea
South Korea Gene Therapy Market 2018-2032 USD Billion
South Korea Gene Therapy Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 277.14 USD Billion
- Projected Market Size (2032): 1,142.92 USD Billion
- CAGR (2025-2032): 28.70%
Key Findings of South Korea Gene Therapy Market
- The South Korea Gene Therapy Market was valued at 277.14 USD Billion in 2024.
- The South Korea Gene Therapy Market is likely to grow at a CAGR of 28.70% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Viral Vector in Vector Segment accounted for the largest share of the market with a revenue of 216.76 USD Billion
- The fastest growing segment Oncological Disorders in Application Segment grew Fastest with a CAGR of 31.67% during the forecast period from 2024 to 2032.
South Korea Gene Therapy Market Scope
South Korea Gene Therapy Market Segmentation & Scope
Application
- Other Diseases
- Neurological Disorders
- Rare Diseases
- Infectious Disease
- Cardiovascular Diseases
- Oncological Disorders
Method
- In-Vivo
- Ex-Vivo
Vector
- Non-Viral Vector
- Viral Vector
End User
- Others
- Research Institutes
- Hospitals
- Cancer Institutes
South Korea Gene Therapy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 277.14 USD Billion |
| Market Value in 2032 | 1,142.92 USD Billion |
| CAGR (2025-2032) | 28.70% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Application,Method,Vector,End User |
Regional Insights:
-
Leading Market (2024-2032): South Korea, leading in terms of revenue 277.14 USD Billion in 2024
- Key Country: South Korea, leading in terms of revenue with value of 277.14 USD Billion in 2024.
Segments and Scope
-
South Korea Gene Therapy Market to 2032, By Application
- Oncological Disorders is the largest segment in South Korea Gene Therapy Market to 2032 with a revenue of 131.59 USD Billion in the year 2024.
- Oncological Disorders is the Fastest growing segment in South Korea Gene Therapy Market to 2032 with a Growth rate of 31.67 % in forecast period 2025-2032.
-
South Korea Gene Therapy Market to 2032, By Method
- Ex-Vivo is the largest segment in South Korea Gene Therapy Market to 2032 with a revenue of 211.83 USD Billion in the year 2024.
- Ex-Vivo is the Fastest growing segment in South Korea Gene Therapy Market to 2032 with a Growth rate of 29.87 % in forecast period 2025-2032.
-
South Korea Gene Therapy Market to 2032, By Vector
- Viral Vector is the largest segment in South Korea Gene Therapy Market to 2032 with a revenue of 216.76 USD Billion in the year 2024.
- Viral Vector is the Fastest growing segment in South Korea Gene Therapy Market to 2032 with a Growth rate of 29.90 % in forecast period 2025-2032.
-
South Korea Gene Therapy Market to 2032, By End User
- Cancer Institutes is the largest segment in South Korea Gene Therapy Market to 2032 with a revenue of 124.19 USD Billion in the year 2024.
- Cancer Institutes is the Fastest growing segment in South Korea Gene Therapy Market to 2032 with a Growth rate of 30.45 % in forecast period 2025-2032.
South Korea Gene Therapy Market Company Share Analysis
| Company Name |
|
||
| Oxford Biomedica | |||
| Novartis AG | |||
| Kite Pharma Inc. | |||
| Biogen | |||
| Bristol-Myers Squibb Company | |||
South Korea Gene Therapy Market Geographical Sales Distribution, 2018-2032 USD Billion
South Korea Gene Therapy Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The South Korea Gene Therapy Market is segmented based on Segmentation Application,Method,Vector,End User.
South Korea Gene Therapy Market was valued at USD 277.14(Revenue in USD Billion) in 2021.
South Korea Gene Therapy Market is projected to grow at a CAGR of 28.70% during the forecast period of 2024 to 2032.
The Viral Vector segment is expected to dominate the South Korea Gene Therapy Market, holding a largest market share of 216.76 USD Billion in 2024
South Korea Gene Therapy Market Scope
South Korea Gene Therapy Market Segmentation & Scope
Application
- Other Diseases
- Neurological Disorders
- Rare Diseases
- Infectious Disease
- Cardiovascular Diseases
- Oncological Disorders
Method
- In-Vivo
- Ex-Vivo
Vector
- Non-Viral Vector
- Viral Vector
End User
- Others
- Research Institutes
- Hospitals
- Cancer Institutes
Frequently Asked Questions
The South Korea Gene Therapy Market is segmented based on Segmentation Application,Method,Vector,End User.
South Korea Gene Therapy Market was valued at USD 277.14(Revenue in USD Billion) in 2021.
South Korea Gene Therapy Market is projected to grow at a CAGR of 28.70% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Gene Therapy Market for final year is USD 1,142.92 (USD Billion).
South Korea Gene Therapy Market Company Profiling
Frequently Asked Questions
The South Korea Gene Therapy Market is segmented based on Segmentation Application,Method,Vector,End User.
South Korea Gene Therapy Market was valued at USD 277.14(Revenue in USD Billion) in 2021.
South Korea Gene Therapy Market is projected to grow at a CAGR of 28.70% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Gene Therapy Market for final year is USD 1,142.92 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.